Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers

Paul Cairns; Ella Evron; Kenji Okami; Naomi Halachmi; Manel Esteller; James G. Herman; Shikha Bose; Steven I. Wang; Ramon Parsons; David Sidransky

doi:10.1038/sj.onc.1201855

Related publications

Article1997

Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.

P Cairns, Kenji Okami, Sarel Halachmi, Naomi Halachmi, Manel Esteller, James G. Herman, Jin Jen, William B. Isaacs, G. Steven Bova, David Sidransky

Article2002

Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma

Christian A. Koch, Steve Huang, Zhengping Zhuang, Catherine A. Stolle, Norio Azumi, George Chrousos, Alexander O. Vortmeyer, Karel Pacák

Article2007

Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers

G. Randi, Claudio Pelucchi, Eva Negri, Renato Talamini, Carlotta Galeone, Silvia Franceschi, Carlo La Vecchia

Letter2016

Association of<i>CFHR1</i>homozygous deletion with acute myelogenous leukemia in the European population

Maddalena Fratelli, Marco Bolis, Mami Kurosaki, Martina Dori, Valeria Guarnaccia, Orietta Spinelli, Marta Alberti, Elisabetta Valoti, Silvana Pileggi, Marina Noris, Giuseppe Remuzzi, Alessandro Rambaldi, Mineko Terao, Enrico Garattini

Article2012

A Novel Point Mutation in the KCNJ5 Gene Causing Primary Hyperaldosteronism and Early-Onset Autosomal Dominant Hypertension

Amalia Sertedaki, Tomoshige Kino, Christina Merakou, Dax A. Hoffman, Michael M. Hatch, Darrell E. Hurt, Lin Lin, Paraskevi Xekouki, Constantine A. Stratakis, George Chrousos, Evangelia Charmandari